Close Menu

NEW YORK (GenomeWeb) – Australian molecular diagnostics firm Genetic Technologies said on Wednesday that it has entered into a securities purchase agreement with certain institutional investors in the US.

Under the agreement, the investors will purchase approximately 1.5 million American Depository Shares (ADS), each representing 150 of the company's ordinary shares, at a price of $.80 per ADS.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.